News | September 07, 2021
Panacea Biotech supplies 1st shipment of the second component of Sputnik V vaccine
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
The batch will be distributed in India through a partner of RDIF and Panacea Biotec - Dr. Reddy's Laboratories
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
This is the first of its kind vaccine for Covid 19 to get the go-ahead
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
AstraZeneca, Sinopharm and Moderna were part of the study
The first batch will be shipped to the Gamaleya Center for the quality control
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
Market penetration of Sputnik V will depend on competitive pricing, government orders and the ability to meet soaring demand through timely supply
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS
Subscribe To Our Newsletter & Stay Updated
